Evolutionsbiologische Erklärung der Alzheimerentstehung − Mikronährstoffe in Prävention und Therapie

Zusammenfassung

Chronischer Stress, Mangel an Mikronährstoffen, fehlende Bewegung und andere Faktoren der Lebensweise lösen eine Kausalkette aus. Diese beginnt mit einer gestörten hippocampalen Neurogenese, die zunächst zu einem erhöhten Stresshormonlevel führt, dann zu Depressionen und letztendlich zu den für Alzheimer typischen neuropathologischen und kognitiven Veränderungen. Durch Beheben der Mängel lässt sich Alzheimer vermeiden und im Frühstadium der Erkrankung sogar therapieren.

Schlüsselwörter

Alzheimerdemenz - β-Amyloidstoffwechsel - adulte Neurogenese - Hippocampus - Stress - Minimumgesetz - Mikronährstoffe

• Literatur

• 1 James BD et al. Contribution of Alzheimer disease to mortality in the United States. Neurology 2014; 82: 1045-1050
• 2 Tu S, Okamoto S, Lipton SA, Xu H. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease. Mol Neurodegener 2014; 1750-1326
• 3 Nelson PT et al. Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011; 121: 571-587
• 4 Lahdenperä M. Fitness benefits of prolonged post reproductive lifespan in women. Nature 2004; 428: 178-181
• 5 Brent JN. Ecological knowledge, leadership, and the evolution of menopause in Killer Whales. Current Biology 2015; 25: 746-750
• 6 Gurven M, Kaplan H. Longevity among hunter-gatherers: A cross-cultural examination. Population and Development Review 2007; 33: 321-365
• 7 Spalding KL et al. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013; 153: 1219-1227
• 8 Nehls M. Die Alzheimer-Lüge − Die Wahrheit über eine vermeidbare Krankheit. München: Heyne; 2014
• 9 Du X, Pang TY. Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?. Front Psychiatry 2015; eCollection 2015
• 10 Dranovsky A, Leonardo ED. Is there a role for young hippocampal neurons in adaptation to stress?. Behav Brain Res 2012; 227: 371-375
• 11 Nehls M. Alzheimer ist heilbar − Rechtzeitig zurück in ein gesundes Leben. München: Heyne; 2015
• 12 Walker LC et al. Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurology 2013; 70: 304-310
• 13 Stöhr J et al. Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions. PNAS USA 2012; 109: 11025-11030
• 14 Cardoso BR et al. Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease. Clin Interv Aging 2013; 8: 531-542
• 15 Szewczyk B et al. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsy-chopharmacol Biol Psychiatry 2011; 35: 693-701
• 16 Conner TS et al. Optimal serum selenium concentrations are associated with lower depressive symptoms and negative mood among young adults. J Nutr 2015; 145: 59-65
• 17 Zhu Y et al. Abnormal neurogenesis in the dentate gyrus of adult mice lacking 1,25-dihydroxy vitamin D3 (1,25-(OH)2 D3). Hippocampus 2012; 22: 421-433
• 18 Littlejohns TJ et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology 2014; 83: 920-928
• 19 Smith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One; 2010. www.ncbi.nlm.nih.gov/pubmed/20838622
• 20 Shin JY et al. Elevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian model. PLoS One; 2012. www.ncbi.nlm.nih.gov/pubmed/23209759
• 21 Fiorentini A et al. Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS One; 2010. www.ncbi.nlm.nih.gov/pubmed/21187954
• 22 Ishii N et al. Low risk of male suicide and lithium in drinking water. J Clin Psychiatry 2015; 76: 319-326
• 23 Terao T. Is lithium potentially a trace element?. World J Psychiatry 2015; 5: 1-3
• 24 Nunes MA et al. Micro-dose lithium treatment stabilized cognitive impairment in patients with Alzheimer’s disease. Curr Alzheimer Res 2013; 10: 104-107